Mechanistic description
This hypothesis proposes that the CREB-BDNF-TrkB activity-dependent signaling cascade directly controls the spatial positioning and expression levels of complement regulators CD55 and CD46 on synaptic membranes, creating an activity-based tagging system for synaptic elimination. High-frequency neural activity triggers calcium influx and CaMKIV/PKA-mediated CREB1 phosphorylation at serine 133, which transcriptionally upregulates CD55 and CD46 expression while simultaneously promoting their trafficking to active synapses through BDNF-TrkB signaling. The TrkB-activated PI3K/Akt pathway enhances surface insertion of CD55/CD46 at frequently stimulated synapses by phosphorylating trafficking proteins and stabilizing regulator clustering, while the Ras/MAPK cascade reinforces this protective phenotype through sustained CREB activation. Conversely, synapses with low activity levels exhibit reduced CREB-mediated transcription, leading to diminished CD55 and CD46 surface expression and creating microdomains of complement vulnerability. This activity-dependent complement regulator positioning enables precise targeting of weak or silent synapses for complement-mediated pruning while protecting active, functional connections. The differential CD55/CD46 expression creates distinct complement convertase decay rates across synaptic populations—active synapses rapidly dissociate C3 and C5 convertases through high CD55 levels and efficiently cleave complement components via CD46-factor I interactions, while inactive synapses become susceptible to complement deposition and membrane attack complex formation. This mechanism provides a molecular explanation for experience-dependent synaptic refinement during critical periods and may be dysregulated in neurodevelopmental disorders characterized by aberrant pruning.
Mechanism / pathway
- CREB1, CD55, CD46
- CREB-mediated complement regulator expression and trafficking
- synaptic biology
Evidence for (9)
CD55 protects synapses from complement-mediated damage
C3aR1 mediates microglial recruitment to injured neurons
Dendritic spine CD46 expression is activity-dependent
Beyond the Role of CD55 as a Complement Component.
Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade.
Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells.
Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide.
Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer.
CD46 cofactor activity at active synapses enhances factor I-mediated cleavage of C3b and C4b, blocking complement amplification on synaptic membranes
Evidence against (2)
C1q binding can occur independent of complement cascade initiation through pattern recognition
Global complement enhancement could impair necessary synaptic remodeling
Evidence matrix
Supporting
- CD55 protects synapses from complement-mediated damage PMID:31611251
- C3aR1 mediates microglial recruitment to injured neurons PMID:25361907
- Dendritic spine CD46 expression is activity-dependent PMID:28902832
- Beyond the Role of CD55 as a Complement Component. PMID:29503741 · 2018 · Immune Netw
- Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade. PMID:36271172 · 2022 · Nat Cancer
- Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells. PMID:22574734 · 2012 · Cell Biol Int
- Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide. PMID:23176121 · 2013 · FEBS J
- Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer. PMID:38853277 · 2024 · Mol Cancer
- CD46 cofactor activity at active synapses enhances factor I-mediated cleavage of C3b and C4b, blocking complement amplification on synaptic membranes PMID:37515111
Contradicting
- C1q binding can occur independent of complement cascade initiation through pattern recognition PMID:29257131
- Global complement enhancement could impair necessary synaptic remodeling PMID:24962259
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). CREB-Dependent Differential Complement Regulator Positioning for Activity-Based…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-var-92a02b86a1
@misc{scidex_hypothesis_hvar92a0,
title = {CREB-Dependent Differential Complement Regulator Positioning for Activity-Based…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-var-92a02b86a1},
note = {SciDEX artifact hypothesis:h-var-92a02b86a1}
}